Importance of optimal dosing ≥30 mg/kg/d during deferasirox treatment: 2.7-yr follow-up from the ESCALATOR study in patients with β-thalassaemia
In: European Journal of Haematology, Jg. 87 (2011-10-01), Heft 4, S. 355-356
Online
academicJournal
Zugriff:
Titel: |
Importance of optimal dosing ≥30 mg/kg/d during deferasirox treatment: 2.7-yr follow-up from the ESCALATOR study in patients with β-thalassaemia
|
---|---|
Autor/in / Beteiligte Person: | Taher, Ali ; Elalfy, Mohsen S. ; Al Zir, Kusai ; Daar, Shahina ; Al Jefri, Abdullah ; Habr, Dany ; Kriemler-Krahn, Ulrike ; El-Ali, Ali ; Roubert, Bernard ; El-Beshlawy, Amal |
Link: | |
Zeitschrift: | European Journal of Haematology, Jg. 87 (2011-10-01), Heft 4, S. 355-356 |
Veröffentlichung: | 2011 |
Medientyp: | academicJournal |
ISSN: | 0902-4441 (print) |
DOI: | 10.1111/j.1600-0609.2011.01662.x |
Sonstiges: |
|